| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 7,350 | 5,450 |
| Effect of exchange rate changes on cash and cash equivalents | -26 | 0 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -8,817 | -7,143 |
| Cash and cash equivalents at beginning of period | 12,865 | - |
| Cash and cash equivalents at end of period | 4,048 | - |
Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics, Inc. (RNTX)